Latest Asian Markets News

Platformo Ltd’s Biztrak business reported a robust 41% revenue increase in the June 2025 quarter, driven by software enhancements and training tied to Malaysia’s evolving e-invoicing regulations. The company also tightened cost controls, reducing net cash outflow while preparing for upcoming compliance deadlines.

Compumedics has secured two significant four-year distribution agreements in China worth A$24.4 million, reinforcing its strategic foothold in Asia with committed annual growth of at least 10%.

Mindax Limited has secured an option to acquire Norton Goldfields’ 35% stake in the Mt Forrest magnetite project, potentially gaining full ownership of a major iron ore asset in Western Australia’s Mid-West region.

Firebrick Pharma has published positive Phase 3 clinical trial results for its Nasodine nasal spray, showing efficacy against the common cold, while reporting encouraging sales growth in Singapore and the US. However, a recent capital raise fell well short of targets, casting uncertainty over its expansion plans.

Coast Entertainment Holdings reports a robust FY25 with double-digit growth in visitation and revenue, driven by new attractions and strong promotional campaigns. Despite weather disruptions and cautious international recovery, the company starts FY26 on a high note.

Macro Metals Limited and WA Limestone have completed the acquisition of the Derby East Construction Sands Project near Derby, WA, positioning themselves to tap into growing Southeast Asian sand markets. The project offers low-risk mining potential with strong logistics links to the Port of Derby.

Whitebark Energy has completed a crucial cultural heritage survey at its Alinya Project, paving the way for soil geochemistry testing aimed at unlocking hydrogen, helium, and hydrocarbons in one of Australia’s largest undrilled sub-salt structures.

United Overseas Australia Ltd has signed a binding agreement to acquire a strategic land parcel in Ho Chi Minh City, aiming to develop a substantial commercial office building. The AU$104.7 million deal marks a significant expansion into Vietnam’s growing property market.

Race Oncology has secured key ethics approvals to launch its Phase 1 RC220 trial at two major Hong Kong hospitals, marking a strategic expansion beyond Australia to accelerate patient recruitment and explore cardioprotective benefits.

Anatara Lifesciences has strengthened its intellectual property portfolio with a Japanese patent for its GaRP gastrointestinal health product, while progressing pre-clinical studies in its Anti-Obesity Project. The company also confirmed registration of its R&D Tax Incentive application for 2024-2025.

BlackRock Investment Management has announced an estimated distribution of 317.02 cents per unit for the iShares Asia 50 ETF for the period ending June 30, 2025, with a detailed breakdown of income sources and tax components.

Green Critical Minerals has released a robust Pre-Feasibility Study for the McIntosh Graphite Project, highlighting significant economic potential and a long mine life. Meanwhile, NH3 Clean Energy advances its flagship WAH2 ammonia project towards key development milestones.